Amylyx Pharmaceuticals AMLX Growth Metrics (2021-2026)

NASDAQ AMLX
$29.03 +0.26 (+0.90%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Amylyx Pharmaceuticals Quarterly Growth Metrics

Periods 21 quarters
Latest Jun 2026

Amylyx Pharmaceuticals reported asset growth of 35.95% for the quarter ended Jun 2026. These growth metrics cover 21 quarters of results from Jun 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
270.64%48.65%101.38%157.15%32.19%2.33%-26.77%-46.27%-62.58%-47.38%-41.41%44.68%71.79%33.65%35.95%
Assets Growth (3y)
22.39%-7.15%-4.76%25.98%-5.28%-10.38%-16.45%
Assets (QoQ)
159.85%-17.93%-19.44%115.74%4.22%11.18%2.87%10.90%-19.32%-20.43%-24.52%-22.77%13.45%-11.42%86.41%-8.30%-11.74%-9.89%
Capital Expenditures Growth (1y)Capex Growth (1y)
2,342.86%200.00%233.33%-26.90%-74.84%-22.22%-42.58%-73.20%-67.99%-105.32%-94.38%-83.58%-80.90%226.32%330.00%
Capital Expenditures Growth (3y)Capex Growth (3y)
68.52%-28.55%-52.45%-68.20%-75.13%-62.61%-48.24%
Capital Expenditures (QoQ)Capex (QoQ)
21.57%83.87%223.10%-58.46%35.08%-59.68%11.20%28.42%-0.28%-81.18%32.84%-121.35%205.26%-45.00%54.55%41.18%258.33%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
24.58%3.77%267.38%25.55%172.21%48.87%-69.73%-46.89%-54.53%-64.96%-22.55%213.45%192.86%283.40%-15.08%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
15.53%-18.50%-4.86%27.86%53.61%25.99%-41.61%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
119.97%-38.91%59.75%-41.96%83.22%116.27%-45.41%25.83%0.21%-56.03%-4.21%7.73%-22.78%-2.81%287.67%0.65%1.10%-78.47%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
-709,264.29%270.79%-8,208.74%156.38%2,661.59%-228.61%109.17%-98.54%-123.50%135.91%210.54%-5,430.77%179.40%-86.51%-54.65%183.06%-751.46%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
292.57%40.76%184.76%23.96%72.73%-60.36%28.65%-13.48%-47.60%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
381.65%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
105.72%-3,629.18%104.49%1,783.48%-371.51%124.54%120.06%-187.72%119.36%-96.09%-3,636.14%234.03%67.41%-167.19%152.67%-77.23%462.80%23.06%-513.10%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-221.40%-256.11%-106.46%-75.96%87.52%118.53%88.00%127.27%90.36%-873.38%-704.22%-535.45%-8,043.97%62.08%26.95%52.71%7.39%-24.46%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
66.18%-72.16%-25.83%-27.84%0.67%18.40%11.00%17.50%-93.74%-78.11%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-23.88%-19.22%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-59.92%-35.37%-43.87%-14.34%7.28%-15.37%89.79%269.74%-160.04%362.16%-103.61%-13,515.54%37.56%-41.95%32.51%36.60%-20.28%8.12%-32.18%14.80%
EBITDA Margin Growth (1y)
-0.78M1.58M0.02M-0.01M-0.75M-1.82M
EBITDA Margin Growth (3y)
-1.01M
EBITDA Margin (QoQ)
1.56M0.02M0.00M-233.000.00M-0.01M-0.73M-1.07M
EBIT Growth (1y)
-271.57%-191.89%-138.59%-57.49%95.71%137.23%134.23%104.34%-5,848.86%-477.63%-504.17%-2,202.07%69.05%43.82%52.38%9.96%-15.81%-6.62%
EBIT Growth (3y)
-111.72%-60.11%-48.90%-12.81%7.53%7.56%12.98%6.37%-177.31%-62.13%
EBIT Growth (5y)
-27.75%-19.71%
EBIT Margin Growth (1y)
-0.78M1.59M0.02M-0.01M-0.75M-1.82M
EBIT Margin Growth (3y)
-1.01M
EBIT Margin (QoQ)
1.56M0.02M0.00M-234.000.00M-0.01M-0.73M-1.07M
EBIT (QoQ)
-23.30%-23.55%-68.86%-13.47%-0.79%18.45%95.40%1,083.97%-7.33%-89.67%-6,414.89%37.54%0.82%46.27%7.01%-13.37%15.94%-1.60%-19.60%-4.37%
EBT Growth (1y)
-228.46%-145.84%-132.83%-48.62%102.94%144.55%141.59%115.37%-8,549.82%-402.83%-424.41%-689.58%69.71%42.99%52.70%13.69%-14.77%-4.65%
EBT Growth (3y)
-101.35%-49.13%-46.46%-10.44%9.03%8.38%13.90%7.86%-215.39%-56.14%
EBT Growth (5y)
-23.19%-14.62%
EBT Margin Growth (1y)
-0.75M1.56M0.02M-0.01M-0.71M-1.75M
EBT Margin Growth (3y)
-0.94M
EBT Margin (QoQ)
1.54M0.02M0.00M-262.000.00M-0.01M-0.70M-1.04M
EBT (QoQ)
-5.57%-22.48%-68.30%-12.98%0.02%21.82%103.33%1,611.12%-6.65%-71.10%-1,930.62%38.68%-0.01%47.48%5.96%-15.42%17.03%4.17%-25.05%-5.24%
EPS (Basic) Growth (1y)
60.20%72.77%73.18%83.04%102.54%135.39%133.75%109.64%-7,525.45%-425.52%-444.52%-883.05%76.07%56.50%65.50%36.67%10.88%16.01%
EPS (Basic) Growth (3y)
9.08%32.06%32.19%49.60%23.26%20.57%26.25%21.81%-161.28%-47.20%
EPS (Basic) Growth (5y)
30.66%35.16%
EPS (Basic) (QoQ)
-0.51%-25.65%78.45%-0.06%1.01%20.51%103.23%1,292.53%-5.60%-77.30%-2,588.01%38.95%0.09%48.40%23.96%-10.96%20.76%5.28%-7.00%-4.58%
EPS (Diluted) Growth (1y)
72.77%73.18%83.04%102.39%133.93%132.62%109.26%-7,986.93%-439.55%-456.45%-915.15%76.07%56.50%65.50%36.67%10.88%16.01%
EPS (Diluted) Growth (3y)
32.06%32.19%49.60%23.26%20.57%26.25%21.81%-166.00%-47.98%
EPS (Diluted) Growth (5y)
35.16%
EPS (Diluted) (QoQ)
-0.51%-25.65%78.45%-0.06%1.01%20.51%103.04%1,317.95%-4.83%-77.43%-2,690.03%38.95%0.09%48.40%23.96%-10.96%20.76%5.28%-7.00%-4.58%
FCF Margin Growth (1y)
-0.52M1.26M0.02M682.00-0.65M-1.00M
FCF Margin Growth (3y)
-0.26M
FCF Margin (QoQ)
1.24M0.02M0.00M0.00M0.00M0.00M-0.65M-0.35M
Free Cash Flow Growth (1y)FCF Growth (1y)
-223.74%-264.58%-107.14%-76.99%87.01%117.51%87.31%126.22%89.55%-900.25%-651.92%-547.35%-7,064.57%62.10%26.86%52.58%7.41%-24.38%
Free Cash Flow Growth (3y)FCF Growth (3y)
64.72%-72.24%-25.51%-27.57%0.94%19.02%11.29%17.76%-90.65%-79.38%
Free Cash Flow Growth (5y)FCF Growth (5y)
-23.85%-19.22%
Free Cash Flow (QoQ)FCF (QoQ)
-61.09%-35.27%-44.13%-16.09%8.47%-15.57%89.42%256.54%-166.33%338.78%-104.21%-11,890.83%37.68%-42.06%32.52%36.58%-20.29%7.91%-31.77%14.80%
Gross Margin Growth (1y)
0.00M426.0069.00490.00508.00
Gross Margin (QoQ)
0.00M549.00171.0060.00-355.00192.00592.0078.00
Gross Profit Growth (1y)
56,243.93%419.77%25.03%-98.90%-99.57%-100.64%
Gross Profit (QoQ)
10,919.65%246.96%40.05%5.22%1.66%-16.54%-98.77%-59.01%-252.88%
Net Cash Flow Growth (1y)NCF Growth (1y)
355.99%-287.44%-33.48%-72.54%-14.13%411.05%-374.32%175.92%-99.11%-171.70%97.62%-82.48%-3,965.73%97.61%6,325.65%-77.69%114.57%-7,766.17%
Net Cash Flow Growth (3y)NCF Growth (3y)
-67.37%-105.20%-26.90%30.64%-31.90%62.35%59.58%26.61%-63.16%-49.62%
Net Cash Flow Growth (5y)NCF Growth (5y)
-27.84%-74.67%
Net Cash Flow (QoQ)NCF (QoQ)
657.08%-143.03%328.38%-170.78%195.65%-211.60%213.67%156.37%-184.35%130.89%-98.67%-20,818.87%97.20%327.45%-393.01%87.18%7,385.51%-99.18%91.38%-7,021.14%
Net Income Growth (1y)
-229.46%-146.63%-132.29%-50.66%103.29%140.83%138.87%111.08%-7,652.00%-429.35%-447.98%-893.62%69.77%42.99%52.70%12.11%-14.97%-4.78%
Net Income Growth (3y)
-101.49%-49.13%-46.46%-9.82%9.13%8.48%13.84%8.23%-204.54%-58.30%
Net Income Growth (5y)
-23.24%-14.65%
Net Income (QoQ)
-5.57%-22.48%-68.81%-13.00%0.58%20.56%103.68%1,303.31%-5.35%-77.36%-2,610.95%38.80%-0.01%48.36%4.37%-15.42%17.03%4.03%-25.11%-5.18%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-229.46%-146.63%-132.29%-50.66%103.29%140.83%138.87%111.08%-7,652.00%-429.35%-447.98%-893.62%69.77%42.99%52.70%12.11%-14.97%-4.78%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-101.49%-49.13%-46.46%-9.82%9.13%8.48%13.84%8.23%-204.54%-58.30%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-23.24%-14.65%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-5.57%-22.48%-68.81%-13.00%0.58%20.56%103.68%1,303.31%-5.35%-77.36%-2,610.95%38.80%-0.01%48.36%4.37%-15.42%17.03%4.03%-25.11%-5.18%
Net Margin Growth (1y)
-0.75M1.56M0.02M-0.01M-0.71M-1.75M
Net Margin Growth (3y)
-0.94M
Net Margin (QoQ)
1.54M0.02M0.00M-213.000.00M-0.01M-0.70M-1.04M
Operating Income Growth (1y)Op. Inc Growth (1y)
-271.57%-191.89%-138.59%-57.49%95.71%137.23%134.23%104.34%-5,848.86%-477.63%-504.17%-2,202.07%69.05%43.82%52.38%9.96%-15.81%-6.62%
Operating Income Growth (3y)Op. Inc Growth (3y)
-111.72%-60.11%-48.90%-12.81%7.53%7.56%12.98%6.37%-177.31%-62.13%
Operating Income Growth (5y)Op. Inc Growth (5y)
-27.75%-19.71%
Operating Income (QoQ)Op. Inc (QoQ)
-23.30%-23.55%-68.86%-13.47%-0.79%18.45%95.40%1,083.97%-7.33%-89.67%-6,414.89%37.54%0.82%46.27%7.01%-13.37%15.94%-1.60%-19.60%-4.37%
Operating Margin Growth (1y)
-0.78M1.59M0.02M-0.01M-0.75M-1.82M
Operating Margin Growth (3y)
-1.01M
Operating Margin (QoQ)
1.56M0.02M0.00M-234.000.00M-0.01M-0.73M-1.07M
Profit After Tax Growth (1y)PAT Growth (1y)
-229.46%-146.75%-132.29%-50.65%103.29%140.81%138.87%111.08%-7,652.00%-429.35%-447.98%-893.62%69.77%42.99%52.70%12.11%-14.77%-4.65%
Profit After Tax Growth (3y)PAT Growth (3y)
-101.49%-49.13%-46.46%-9.82%9.13%8.50%13.84%8.23%-204.37%-58.27%
Profit After Tax Growth (5y)PAT Growth (5y)
-23.19%-14.62%
Profit After Tax (QoQ)PAT (QoQ)
-5.57%-22.48%-68.81%-13.05%0.62%20.57%103.68%1,303.31%-5.35%-77.36%-2,610.95%38.80%-0.01%48.36%4.37%-15.42%17.03%4.03%-24.88%-5.24%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
450.84%98.37%42.00%30.36%2.87%-3.91%-44.14%-54.65%-64.22%-66.82%-69.79%-68.13%-67.74%-74.02%-55.28%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
26.57%-14.16%-37.89%-42.67%-50.85%-56.41%-57.74%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
172.15%43.95%14.05%23.28%-1.99%3.05%4.70%-2.72%-8.45%-40.10%-15.00%-23.24%-15.09%-45.47%-10.34%-22.31%-31.61%-6.13%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M0.01M0.01M0.00M0.00M-0.01M-0.01M-0.01M0.00M0.00M0.01M0.01M0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.00M0.00M0.00M0.00M0.00M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
240.000.00M0.00M0.00M0.00M0.00M961.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-629.00-653.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M0.00M0.01M0.01M0.00M0.00M-0.01M-0.02M-0.01M0.00M0.01M0.01M0.01M0.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.00M0.00M0.00M0.00M-890.000.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
363.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-0.01M0.00M0.00M0.00M0.00M0.00M-643.00-925.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.02M0.01M0.01M0.01M0.00M0.00M-0.01M-0.02M-0.01M0.00M0.01M0.01M0.01M0.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.02M0.00M0.00M0.00M-890.000.00M
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.02M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-0.01M-0.01M0.00M0.00M0.00M0.00M-645.00-744.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-0.78M1.59M0.02M-0.01M-0.75M-1.82M-0.04M-2.86M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-1.01M
Return on Sales [ROS] (QoQ)ROS (QoQ)
1.56M0.02M0.00M-234.000.00M-0.01M-0.73M-1.07M1.78M-2.83M
Revenue Growth (1y)
21.05%29,666.09%395.54%24.10%-98.96%-99.59%-100.59%
Revenue Growth (3y)
13.44%
Revenue (QoQ)
6,243.48%226.38%37.50%4.56%5.61%-18.26%-98.85%-59.34%-252.88%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
649.49%768.65%588.78%458.30%70.79%74.35%84.21%56.53%32.30%-3.82%-33.15%-29.30%-31.15%-23.20%4.01%-5.27%-10.43%13.17%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
156.80%144.22%103.94%83.50%15.87%8.80%8.60%1.59%-6.56%-5.80%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
59.87%66.15%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
22.07%36.03%302.57%29.94%-3.21%10.26%23.15%32.65%2.27%-6.31%4.09%-3.57%-28.91%-0.91%1.36%7.57%-3.73%-9.75%-4.17%35.92%
Tax Rate (QoQ)
-128.000.00M

Amylyx Pharmaceuticals Growth Metrics API

Pull Amylyx Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AMLX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY